British Journal of Pharmacology · 1992 · 232 citations · 9 references
Life SciencesNeurobiologyNeuroscienceNeurochemistryNeuropharmacologyNeurotoxicologyAcute Ischemic StrokeCerebrovascular DiseaseGlutamatergic NeurochemistryNeuroprotectionStrokeCerebral Ischemia NeuroprotectionNeural IschemiaNeuroprotective AgentsNeuroprotective ResponsesNitric OxideNitric Oxide ProductionRodent Cerebral IschemiaStroke Neuroprotection
Recent data showed that glutamate toxicity in primary cortical cultures is mediated by nitric oxide. In order to investigate the effect of inhibition of NO synthase on focal cerebral ischaemia in rats, we studied the histological consequences of a middle cerebral artery (MCA) occlusion after post-operative treatment with NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase. We found a significant reduction of cortical (-43%) and striatal (-25%) necrotic volumes induced by MCA occlusion, indicating that NO synthesis plays an important role in the neurotoxic cascade leading to neuronal damage after focal cerebral ischaemia in rats.
9
The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat
C. K. Park, Daniel G. Nehls, David I. Graham et al. · Annals of Neurology · 1988 · 547 citations
Medicine, Neuroscience, Pharmacology +17